المؤلفون: Taherkhani M; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Khanifar Z; Department of Cardiology, Ahvaz Jundishapur University of Medical Sciences, Shoush, Iran., Taherkhani A; Department of Gastroenterology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Hajishah H; Student Research Committee, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran., Tavasol A; Student Research Committee, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ariantavasol1378@gmail.com.

المصدر: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2024 Sep 06; Vol. 24 (1), pp. 474. Date of Electronic Publication: 2024 Sep 06.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/adverse effects , Rosuvastatin Calcium*/administration & dosage , Rosuvastatin Calcium*/therapeutic use , Acute Coronary Syndrome*/drug therapy , Acute Coronary Syndrome*/blood , Acute Coronary Syndrome*/diagnosis , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Biomarkers*/blood, Humans ; Aged ; Male ; Female ; Treatment Outcome ; Aged, 80 and over ; Iran ; Time Factors ; Age Factors ; Dyslipidemias/drug therapy ; Dyslipidemias/diagnosis ; Dyslipidemias/blood ; Lipids/blood ; Prospective Studies

المؤلفون: Long A; Taiho Oncology, Inc., Princeton, New Jersey, USA., Yamamiya I; Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki, Japan., Valentine M; Celerion, Lincoln, Nebraska, USA., Machnes Z; Celerion, Lincoln, Nebraska, USA., Hangai N; Taiho Oncology, Inc., Princeton, New Jersey, USA., Anderson B; Taiho Oncology, Inc., Princeton, New Jersey, USA., Wacheck V; Taiho Oncology, Inc., Princeton, New Jersey, USA., Gao L; Taiho Oncology, Inc., Princeton, New Jersey, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e70012.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , Rosuvastatin Calcium*/pharmacokinetics , Rosuvastatin Calcium*/administration & dosage , Neoplasm Proteins*/antagonists & inhibitors , Neoplasm Proteins*/metabolism , Digoxin*/pharmacokinetics , Digoxin*/administration & dosage , ATP Binding Cassette Transporter, Subfamily B, Member 1*/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism, Humans ; Adult ; Male ; Female ; Middle Aged ; Young Adult ; Adolescent ; Healthy Volunteers ; Area Under Curve ; ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors ; ATP Binding Cassette Transporter, Subfamily B/metabolism

المؤلفون: Trevillyan JM; Department of Infectious Diseases, Austin Health.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute of Infection and Immunity., Dart A; Department of Cardiology, Alfred Health., Paul E; ANZIC-RC, School of Public Health and Preventive Medicine, Monash University., Dewar EM; Department of Cardiology, Alfred Health., Hall VG; Department of Infectious Diseases, Peter MacCallum Cancer Centre., Hoy JF; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne Australia.

المصدر: AIDS (London, England) [AIDS] 2024 Sep 01; Vol. 38 (11), pp. 1722-1724. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/therapeutic use , Rosuvastatin Calcium*/administration & dosage , HIV Infections*/drug therapy , HIV Infections*/complications , Pulse Wave Analysis* , Cardiovascular Diseases*, Humans ; Male ; Middle Aged ; Double-Blind Method ; Placebos/administration & dosage ; Adult ; Sulfonamides/therapeutic use ; Sulfonamides/pharmacology ; Treatment Outcome ; Pyrimidines ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Fluorobenzenes/therapeutic use

المؤلفون: Muchaili L; HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia., Masenga SK

المصدر: AIDS (London, England) [AIDS] 2024 Sep 01; Vol. 38 (11), pp. 1720-1721. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/complications , Vascular Stiffness*/drug effects , Rosuvastatin Calcium*/adverse effects , Rosuvastatin Calcium*/therapeutic use , Rosuvastatin Calcium*/administration & dosage, Humans ; Male ; Middle Aged ; Adult ; Cardiovascular Diseases ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Treatment Outcome

المؤلفون: Hong SJ; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Lee YJ; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Kang WC; Gachon University College of Medicine, Incheon, Korea., Hong BK; Gangnam Severance Hospital, Seoul, Korea., Lee JY; Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee JB; Daegu Catholic University Medical Center, Daegu, Korea., Yang TH; Inje University Busan Paik Hospital, Busan, Korea., Yoon J; Wonju Severance Christian Hospital, Wonju, Korea., Lee SJ; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Ahn CM; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Kim JS; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Kim BK; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Ko YG; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Choi D; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Jang Y; CHA University College of Medicine, Seongnam, Korea., Hong MK; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. mkhong61@yuhs.ac.; Division of Cardiology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei- ro, Seodaemun-gu, Seoul, 03722, South Korea. mkhong61@yuhs.ac.

مؤلفون مشاركون: LODESTAR investigators

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Aug 07; Vol. 23 (1), pp. 287. Date of Electronic Publication: 2024 Aug 07.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/adverse effects , Rosuvastatin Calcium*/therapeutic use , Atorvastatin*/adverse effects , Atorvastatin*/therapeutic use , Coronary Artery Disease*/epidemiology , Coronary Artery Disease*/blood , Coronary Artery Disease*/diagnosis , Coronary Artery Disease*/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Diabetes Mellitus*/diagnosis , Diabetes Mellitus*/epidemiology , Diabetes Mellitus*/blood , Diabetes Mellitus*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Incidence ; Treatment Outcome ; Risk Factors ; Time Factors ; Biomarkers/blood ; Risk Assessment

المؤلفون: Shehata TM; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf, Al-Ahsa, 36362, Saudi Arabia.; Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Aldhubiab B; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf, Al-Ahsa, 36362, Saudi Arabia., Elsewedy HS; Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 11597, Saudi Arabia.

المصدر: International journal of nanomedicine [Int J Nanomedicine] 2024 Aug 05; Vol. 19, pp. 7945-7961. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/pharmacokinetics , Rosuvastatin Calcium*/chemistry , Rosuvastatin Calcium*/pharmacology , Rosuvastatin Calcium*/administration & dosage , Coconut Oil*/chemistry , Coconut Oil*/pharmacology , Hypolipidemic Agents*/chemistry , Hypolipidemic Agents*/pharmacology , Hypolipidemic Agents*/pharmacokinetics , Hypolipidemic Agents*/administration & dosage , Drug Carriers*/chemistry , Particle Size* , Nanostructures*/chemistry, Animals ; Male ; Rats ; Lipids/chemistry ; Lipids/blood ; Rats, Wistar ; Drug Liberation ; Biological Availability ; Administration, Oral

المؤلفون: Das IJ; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, 835215, India., Kashyap S; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, 835215, India., Jena K; CSB-Central Tasar Research and Training Institute, Central Silk Board, P.O. Piska-Nagri, Ranchi 835303, Jharkhand, India., Sinha A; CSB-Central Tasar Research and Training Institute, Central Silk Board, P.O. Piska-Nagri, Ranchi 835303, Jharkhand, India., Chinnappan BA; Coimbatore Institute of Technology, Coimbatore, India., Rangappa SM; Natural Composites Research Group Lab, Department of Materials and Production Engineering, The Sirindhorn International Thai-German Graduate School of Engineering (TGGS), King Mongkut's University of Technology North Bangkok (KMUTNB), Bangkok, Thailand., Siengchin S; Natural Composites Research Group Lab, Department of Materials and Production Engineering, The Sirindhorn International Thai-German Graduate School of Engineering (TGGS), King Mongkut's University of Technology North Bangkok (KMUTNB), Bangkok, Thailand., Chakroborty S; School of Applied Sciences, Chandigarh University, Lucknow, Uttarpradesh, India., Bal T; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, 835215, India. Electronic address: trishna.bal@gmail.com.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 Aug; Vol. 275 (Pt 2), pp. 133200. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: Acrylic Resins*/chemistry , Microwaves* , Delayed-Action Preparations* , Drug Liberation* , Rosuvastatin Calcium*/chemistry , Rosuvastatin Calcium*/pharmacology , Plant Leaves*/chemistry , Opuntia*/chemistry, Plant Mucilage/chemistry ; Drug Carriers/chemistry ; Polymers/chemistry ; Animals

المؤلفون: Kim JH; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Republic of Korea., Hong JH; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.; Department of Pharmacology, Chungnam National University College of Medicine, Daejeon, Republic of Korea., Jung JG; Department of Family Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Jung WT; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Nam KY; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Roh JS; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Choi YW; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Bang J; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Huh H; Korea United Pharmaceutical Corporation, Seoul, Republic of Korea., Lee HJ; Caleb Multilab Corporation, Seoul, Republic of Korea., Moon J; Caleb Multilab Corporation, Seoul, Republic of Korea., Kim J; Caleb Multilab Corporation, Seoul, Republic of Korea., Sunwoo J; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 842-851. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/pharmacokinetics , Rosuvastatin Calcium*/administration & dosage , Rosuvastatin Calcium*/adverse effects , Cilostazol*/administration & dosage , Cilostazol*/pharmacokinetics , Cilostazol*/adverse effects , Cross-Over Studies* , Drug Combinations* , Area Under Curve* , Healthy Volunteers* , Fasting*/metabolism, Humans ; Male ; Adult ; Female ; Young Adult ; Administration, Oral ; Middle Aged ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Therapeutic Equivalency ; Tandem Mass Spectrometry

المؤلفون: Perez de Isla L; Cardiology Department, Hospital Clínico San Carlos, Servicio de Cardiología, C/Profesor Martín Lagos s/n, 28040, Madrid, Spain. leopisla@hotmail.com., Liberopoulos E; 1st Department of Propedeutic Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Dovizio M; CliCon S.r.l., Società Benefit-Health, Economics and Outcomes Research, Bologna, Italy., Veronesi C; CliCon S.r.l., Società Benefit-Health, Economics and Outcomes Research, Bologna, Italy., Degli Esposti L; CliCon S.r.l., Società Benefit-Health, Economics and Outcomes Research, Bologna, Italy., Zambon A; Department of Medicine, University of Padua Medical School, Padua, Italy.

المصدر: Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3407-3418. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/therapeutic use , Rosuvastatin Calcium*/administration & dosage , Ezetimibe*/therapeutic use , Medication Adherence*/statistics & numerical data , Drug Combinations*, Humans ; Male ; Female ; Retrospective Studies ; Italy ; Aged ; Middle Aged ; Anticholesteremic Agents/therapeutic use ; Anticholesteremic Agents/administration & dosage ; Drug Therapy, Combination ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Cardiovascular Diseases/drug therapy

المؤلفون: Usefi F; Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran., Rustamzadeh A; Cellular and Molecular Research Center, Research Institute for Non-communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.; Department of Anatomical Sciences, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran., Ghobadi Z; Advanced Medical Imaging Ward, Pars Darman Medical Imaging Center, Karaj, Iran., Sadigh N; Department of Emergency Medicine, School of Medicine, Trauma and Injury Research Center, Iran University of Medical Sciences, Tehran, Iran., Mohebi N; Department of Neurology, Rasool Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Ariaei A; Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Moradi F; Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran. f7moradi@gmail.com.

المصدر: Metabolic brain disease [Metab Brain Dis] 2024 Aug; Vol. 39 (6), pp. 1201-1211. Date of Electronic Publication: 2024 Jun 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease*/drug therapy , Alzheimer Disease*/blood , Dyslipidemias*/drug therapy , Dyslipidemias*/blood , MicroRNAs*/blood , Rosuvastatin Calcium*/pharmacology , Rosuvastatin Calcium*/therapeutic use , tau Proteins*/blood, Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers/blood ; Cohort Studies ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use